External

Engineered nanoparticles could deliver better targeted cancer treatment

admin — Wed, 18 Feb 2026 19:42:37 +0000

Scientists at ��VR��Ƶ and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard treatment in a preclinical study.

Feindel Brain and Mind Seminar Series: Drug and Stress Effects on D2 and mGlu5 Receptors: The Transition to Addictions and Their Comorbid Disorders

admin — Wed, 18 Feb 2026 15:21:14 +0000

The Feindel Brain and Mind Seminar Series will advance the vision of Dr. William Feindel (1918–2014), Former Director of the Neuro (1972–1984), to constantly bridge the clinical and research realms.

Special film screening of Tough Old Broads - Free to attend!

admin — Tue, 17 Feb 2026 21:08:34 +0000

Dear Community Members,

Fine particles in pollution are associated with early signs of autoimmune disease

admin — Mon, 15 Dec 2025 14:58:39 +0000

A new study has linked air pollution exposure and immune-system changes that often precede the onset of autoimmune diseases.

��VR��Ƶ researchers analyzing Ontario data found that fine particles in air pollution are associated with higher levels of a biomarker linked with autoimmune diseases, such as systemic lupus.

2026 SCSD Research Day

admin — Wed, 04 Feb 2026 19:51:35 +0000

Friday February 13 2026 • 3pm to 5pm
McIntyre Building, room 330, 3655 Promenade Sir-William-Osler, Montreal QC, H3A 1A3

Availability of respite care almost triples a palliative care patient’s chance of dying at home

admin — Mon, 22 Sep 2025 13:20:18 +0000

Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a ��VR��Ƶ-led study.

Previous surveys suggest most Canadians with a serious illness would prefer to spend the end of their lives at home. In Quebec, fewer than one-in-10 palliative care patients die at home, a rate that has remained largely unchanged for two decades and lags behind the Canadian average of 15 per cent.

��VR��Ƶ researchers awarded funding to strengthen national capacity in metaresearch

admin — Tue, 02 Dec 2025 17:21:44 +0000

Sam Harper and Arijit Nandi have received funding to help strengthen national capacity in metaresearch through the Research-on-Research joint initiative, supported by the Social Sciences and Humanities Research Council (SSHRC), the Canadian Institutes of Health Research (CIHR), and Michael Smith Health Research BC (MSHRBC).

Three ��VR��Ƶ researchers receive SSHRC Partnership Engage Grants

admin — Wed, 14 Jan 2026 16:32:44 +0000

Call for Letters of Intent: Translational Impact Research Program | Cycle 2

admin — Wed, 27 Aug 2025 14:56:59 +0000

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative’s strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

Applicant Eligibility:

This competition is open to:

��VR��Ƶ researchers launch intersex health communication guide

admin — Fri, 03 Oct 2025 13:56:18 +0000

Researchers at ��VR��Ƶ’s Centre of Genomics and Policy (CGP) have launched a first-of-its-kind guide to help Canadian health-care providers offer more inclusive, respectful and affirming care to intersex adults.

��VR��Ƶ Hearing Screening

admin — Thu, 06 Nov 2025 14:39:34 +0000

No appointment needed.

First come, first serve.

Thank you

Group therapy helps cancer survivors reclaim life after treatment

admin — Wed, 03 Dec 2025 14:06:00 +0000

A program developed by a ��VR��Ƶ researcher to help cancer survivors cope with the fear their cancer will return is expanding across Canada.

The Fear of Recurrence Therapy (FORT) program offers evidence-based support to address what co-founder Christine Maheu calls one of the most overlooked aspects of recovery.

Physiology professor Claire M. Brown appointed inaugural Chair for Inclusion in Science and Engineering

admin — Tue, 09 Sep 2025 19:52:07 +0000

Claire M. Brown, Professor in the Department of Physiology, has been selected as Chair for Inclusion in Science and Engineering (CISE) in the province of Quebec. The newly established CISE program is jointly funded by the Natural Sciences and Engineering Research Council (NSERC) and the Fonds de recherche du Québec – Nature et technologies (FRQNT).

Study links early cannabis use and health problems

admin — Tue, 28 Oct 2025 15:11:22 +0000

Adolescents who start using cannabis early and often are more likely to need health care for both mental and physical problems as they enter adulthood, according to a new study led by ��VR��Ƶ researchers.

Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia

admin — Thu, 15 Jan 2026 14:02:20 +0000

A large ��VR��Ƶ study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.

The study examined GLP-1 receptor agonists, which include such medications as Ozempic, as well as DPP-4 inhibitors.